FdaApplication
NDA 022201
Identifiers
- fda_app_no: NDA022201
Properties
| Property | Value |
|---|---|
| applicant_name | FERRING PHARMACEUTICALS INC |
| application_type | NDA |
| approval_date | 2008-12-24 |
Products (2)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| FIRMAGON | DEGARELIX ACETATE | EQ 120MG BASE/VIAL | POWDER;SUBCUTANEOUS |
| FIRMAGON | DEGARELIX ACETATE | EQ 80MG BASE/VIAL | POWDER;SUBCUTANEOUS |
2 products